Lane Medical Library

1A Selected Social History of the Stepping-Stone Drugs /Thomas P. Gullotta1 --2A Biological/Genetic Perspective: The Addicted Brain /Thomas H. Kelly, Alessandra N. Kazura, Karen M. Lommel, Shanna Babalonis, Catherine A. Martin15 --3Individual Characteristics and Needs Associated with Substance Misuse of Adolescents and Young Adults in Addiction Treatment /Michael L. Dennis, Michelle K. White, Melissa L. Ives45 --4Adolescent Substance Abuse Treatment: A Review of Evidence-Based Research /Ken C. Winters, Andria M. Botzet, Tamara Fahnhorst, Randy Stinchfield, Rachel Koskey73 --5Adolescent Outpatient Treatment /Richard Dembo, Randolph D. Muck97 --6Evidence-Based Family Treatment of Adolescent Substance Abuse and Dependence /Shaun I. Calix, Mark A. Fine119 --7Residential Treatment of Adolescents with Substance Use Disorders: Evidence-Based Approaches and Best Practice Recommendations /Robert W. Plant, Peter Panzarella135 --8Primary Prevention in Adolescent Substance Abuse /Martin Bloom, Thomas P. Gullotta155 --9Religious Involvement and Adolescent Substance Use /Terrence D. Hill, Amy M. Burdette, Michael L. Weiss, Dale D. Chitwood171 --10School Prevention /Zili Sloboda191 --11Community Prevention Handbook on Adolescent Substance Abuse Prevention and Treatment: Evidence-Based Practices /Elizabeth J. D'Amico, Matthew Chinman, Stefanie A. Stern, Abraham Wandersman213 --Epilogue: The Status of Knowledge Development and the Unknown /Michele Staton-Tindall, Thomas P. Gullotta, William Walton Stoops, Carl G. Leukefeld251.

All case data presented on the maps were reported to the San Francisco Department of Public Health HIV Epidemiology Section as of January 5, 2012. Population data for calculating the rates of living HIV/AIDS cases and new HIV diagnoses were obtained from the 2010 Census.

Statistical analysis software for analyzing qualitative data, such as focus group discussions, patient interviews and survey results.

v. 1. Learner's guide --v. 2. Tutor's guide.

Female breast cancer in California, an overview / Cyllene R. Morris, Sandy L. Kwong -- Risk factors for female breast cancer / Rosemary D. Cress -- Demographic aspects of breast cancer incidence and mortality in California, 1988-1999 / Sharan L. Campleman, Robyn L. Curtis -- Socioeconomic status and breast cancer incidence in California / Kathleen Yost -- Trends in female breast cancer incidence and mortality in California / Kiumarss Nasseri -- Risk of developing invasive femal breast cancer in California / Cyllene R. Morris -- Utilization of screening mammography in California, 1987-2000 / Holly Hoegh, Bonnie D. Davis -- State at diagnosis of female breast cancer in California, 1988-1999 / Paul K. Mills, Ratnali Jain -- Laterality, derailed site, and histology of female breast cancer, California, 1988-1999 / Sandy L. Kwong -- Surgical treatment of female breast cancer in California / Cyllene R. Morris -- Breast cancer survival in the San Francisco Bay Area / Cynthia O'Malley, Gem Le -- Technical notes.

Includes estimates of cancer incidence and survival rates based on reports from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program. Cancer mortality statistics are derived from Division of Vital Statistics death data.

The epidemiology of cancer in children -- Genetics of childhood malignancies -- Molecular biology of childhood tumours -- The principles for cancer chemotherapy in children -- Future trends in cancer chemotherapy -- Radiotherapy in paediatric oncology -- Surgery in paediatric oncology -- Supportive care during treatment -- Psychosocial issues -- Palliative care -- Late effects of cancer treatment and current protective measures -- Acute lymphoblastic leukaemia -- Acute myeloid leukaemia -- Non-hodgkin lymphoma -- Hodgkin disease -- Langerhans cell histiocytosis -- Tumours of the central nervous system -- Soft tissue sarcoma -- Osteosarcoma -- Ewing sarcoma and peripheral primitive neuroectodermal tumour -- Nephroblastoma -- Nephroblastoma -- Germ cell tumours in children and adolescents -- Hepatic tumours -- Retinoblastoma -- Rare tumours.

CI5 I-VIII: Original Database -- CI5 I-VIII: Updated Database -- CI5 I-VIII: Detailed Database -- WHO -- GLOBOCAN 2002.

Mapping and mapmaking --Medical mapping: early histories --Mapping and statistics: 1830-1849 -- John Snow: the London epidemics -- The cholera debate -- Map as intent: variations on John Snow -- Mapping legacy -- Public health: the divorce -- Disease ecologies: disease atlases -- Complex processes: diffusion and structure -- GIS and medical mapping -- Map thinking: an afterward.

v. 1. Birth to age 14 -- v. 2. Adolescents ages 15 to 19.

Empirical pharmacokinetics -- Numerical methods for PK parameter estimation -- Physiological aspects on pharmacokinetics -- Modelling the distribution process -- PK/PD modelling.

Genetic factors in ethnic disparities in health / Richard S. Cooper -- Race/ethnicity, socioeconomic status, and health / Eileen M. Crimmins, Mark D. Hayward and Teresa E. Seeman -- The role of social and personal resources in ethnic disparities in late-life health / Carlos F. Mendes de Leon and Thomas A. Glass -- What makes a place healthy? neighborhood influences on racial and ethnic disparities in health over the life course / Jeffrey D. Morenoff and John W. Lynch --Racial and ethnic disparities in health behaviors: a challenge to current assumptions / Marilyn A. Winkleby and Catherine Cubbin -- Cumulative psychosocial risks and resilience: a conceptual perspective on ethnic health disparities in late life / Hector F. Myers and Wei-Chin Hwang -- Significance of perceived racism: toward understanding ethnic group disparities in health, the later years / Rodney Clark -- A neurovisceral integration model of health disparities in aging / Julian F. Thayer and Bruce H. Friedman -- Geography and racial health disparities / Amitabh Chandra and Jonathan S. Skinner -- Behavioral health interventions: what works and why? / David M. Cutler -- Ethnic disparities in aging health: what can we learn from the United Kingdom? / James Y. Nazroo -- An exploratory investigation into racial disparities in the health of older South Africans / Debbie Bradshaw ... [et al.].Racial and ethnic identification, official classifications, and health disparities / Gary D. Sandefur, Mary E. Campbell, and Jennifer Eggerling-Boeck -- Racial and ethnic disparities in health and mortality among the U.S. elderly population / Robert A. Hummer, Maureen R. Benjamins, and Richard G. Rogers -- Ethnic differences in dementia and Alzheimer's disease / Jennifer J. Manly and Richard Mayeux -- The life-course contribution to ethnic disparities in health / Clyde Hertzman -- Selection processes in the study of racial and ethnic differentials in adult health and mortality / Alberto Palloni and Douglas C. Ewbank -- Immigrant health: selectivity and acculturation / Guillermina Jasso ... [et al.] --

Maps, figures, and tables present data for defined hospital service areas and referral regions on these topics: hospital resources, expenditures, capacity, utilization, and outcomes; Medicare; physician workforce; diagnosis and surgical treatment of common medical conditions.

A data mining and extraction tool for statistical data from US and international government agencies, including US Census and the National Center for Health Statistics.

Changing patterns of disease and mortality in Sub-Saharan Africa: an overview /Florence K. Baingana and Eduard R. Bos --Levels and trends in mortality in Sub-Saharan Africa: an overview /Jacob Adetunji and Eduard R. Bos --Trends in child mortality, 1960 to 2000 /Kenneth Hill and Agbessi Amouzou --Levels and trends of adult mortality /Debbie Bradshaw and Ian M. Timaeus --Causes of death /Chalapati Rao, Alan D. Lopez, and Yusuf Hemed --Population and mortality after AIDS /Rodolfo A. Bulatao --Levels and patterns of mortality at INDEPTH demographic surveillance systems /Osman A. Sankoh ... [et al.] --Trends and issues in child undernutrition /Todd Benson and Meera Shekar --Diarrheal diseases /Cynthia Boschi-Pinto, Claudio F. Lanata, Walter Mendoza, and Demissie Habte --Developmental disabilities /Geoff Solarsh and Karen J. Hofman --Acute respiratory infections /Shabir A. Mahdi and Keith P. Klugman --Vaccine-preventable diseases /Mark A. Miller and John T. Sentz --Tuberculosis /Christopher Dye ... [et al.] --Malaria /Robert W. Snow and Judy A. Omumbo --Onchocerciasis /Uche Amazigo ... [et al.] --Maternal mortality /Khama O. Rogo, John Oucho, and Philip Mwalali --HIV/AIDS /Souleymane Mboup ... [et al.] --Lifestyle and related risk factors for chronic diseases /Krisela Steyn and Albertino Damasceno --Diabetes mellitus /Jean-Claude Mbanya and Kaushik Ramiaya --Cancers /Freddy Sitas ... [et al.] --Cardiovascular disease /Anthony Mbewu and Jean-Claude Mbanya --Mental health and the abuse of alcohol and controlled substances /Florence K. Baingana, Atalay Alem, and Rachel Jenkins --Neurological disorders /Donald Silberberg and Elly Katabira --Violence and injuries /Brett Bowman ... [et al.].

"This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, and other relevant information. The survey continued to document the prevalence of high-deductible health plans associated with a savings option and included questions on wellness benefits and health risk assessments. The 2010 survey included 3,143 randomly selected public and private firms with three or more employees (2,046 of which responded to the full survey and 1,097 of which responded to an additional question about offering coverage). Researchers at the Kaiser Family Foundation, the National Opinion Research Center at the University of Chicago, and Health Research & Educational Trust designed and analyzed the survey"--Website.

Executive summary -- Outlook -- Trends of average food supply in the European Union -- Food availability at the household level in the European Union -- Energy and nutrient intake in the European Union -- Health indicators and status in the European Union -- General discussion.

Executive summary -- Outlook -- Project background and methodological aspects -- Trends of average food supply in the European Union -- Food availability at the household level in the European Union -- Food consumption in adults on the basis of dietary surveys in European countries -- Energy and nutrient intake in the European Union -- Health and lifestyle indicators in the European Union -- Food and nutrition policies in European countries -- General discussion -- National reports.

Provides access to statistics and information produced by U.S. government agencies.

Provides data by country on HIV/AIDS, tuberculosis, malaria and other key health and socio-econmic indicators.

"This publication presents a comprehensive perspective on the worldwide, regional and country consumption of alcohol, patterns of drinking, health consequences and policy responses in member states. It represents a continuing effort by WHO to support member states with global information in their efforts to reduce the harmful use of alcohol and its health and social consequences"--Publisher's description.

"This report sets out the statistics, evidence and experiences needed to launch a more forceful response to the growing threat posed by noncommunicable diseases. While advice and recommendations are universally relevant, the report gives particular attention to conditions in low- and middle-income countries, which now bear nearly 80% of the burden from diseases like cardiovascular disease, diabetes, cancer and chronic respiratory diseases. The health consequences of the worldwide epidemic of obesity are also addressed. The report takes an analytical approach, using global, regional and country-specific data to document the magnitude of the problem, project future trends, and assess the factors contributing to these trends. As noted, the epidemic of these diseases is being driven by forces now touching every region of the world: demographic aging, rapid unplanned urbanization, and the globalization of unhealthy lifestyles"--Publisher's description.

"Over 1.2 million people die each year on the world' roads, and between 20 and 50 million suffer non-fatal injuries. In most regions of the world this epidemic of road traffic injuries is still increasing. In the past five years most countries have endorsed the recommendations of the World report on road traffic injury prevention which give guidance on how countries can implement a comprehensive approach to improving road safety and reducing the death toll on their roads. To date, however, there has been no global assessment of road safety that indicates the extent to which this approach is being implemented. This Global status report on road safety is the first broad assessment of the status of road safety in 178 countries, using data drawn from a standardized survey conducted in 2008. The results provide a benchmark that countries can use to assess their road safety position relative to other countries, while internationally the data presented can collectively be considered as a global "aseline"against which progress over time can be measured. " - p. [v11]

This report provides legislation data last updated in 2011 and fatality data updated for 2010.

ch. 1. Introduction -- ch. 2. The burden of disease caused by TB -- ch. 3. TB case notifications and treatment outcomes -- ch. 4. Drug-resistant TB -- ch. 5. Diagnostics and laboratory strengthening -- ch. 6. Addressing the co-epidemics of TB and HIV -- ch. 7. Financing -- ch. 8. Research and development.

Provides data by country on HIV/AIDS, tuberculosis, malaria and other key health and socio-econmic indicators.

Information derived from the 2006 HCUP Nationwide Inpatient Sample of 1,000 hospitals. Includes an overview of inpatient stays, stays by diagnosis, procedures, spending for inpatient hospital stays, and priority conditions (cancer, asthma, childbirth, arthritis and depression).

Blue Cross and Blue Shield is committed to extending health insurance to those who do not have coverage, and The Blues® believe the best way to accomplish this goal is to build on our employer-based system. In 2009, more than 95 percent of American firms with more than 50 employees offered health insurance coverage to their employees. However, less than half of companies with fewer than 10 employees offer health benefits. Increasing the percentage of small employers that offer health benefits is critical to increasing coverage levels. Additionally, there must be a focus on those most likely to lack coverage, such as young adults aged 18-34, Hispanics, and African-Americans.

"A federal government website managed by the U.S. Department of Health & Human Services" dedicated to making high value health data more accessible to entrepreneurs, researchers, and policy makers. To accomplish this, HHS has begun making more and more data from HHS' vaults (from CMS, CDC, FDA and NIH, etc.) easily available and accessible to the public and to innovators across the country "liberating" health data through the Health Data Initiative. Includes clinical care provider quality information, nationwide health service provider directories, databases of the latest medical and scientific knowledge, consumer product data, community health performance information, government spending data and more.--Website.

"This report is the last in this series."--P. i.

"Healthy People provides science-based, 10-year national objectives for improving the health of all Americans."

The first cases of what would later become known as AIDS were reported in the United States in June of 1981. Since then, 1.8 million people in the U.S. are estimated to have been infected with HIV, including over 650,000 who have already died and more than 1.1 million estimated to be living with the disease today. The response to the U.S. epidemic has yielded numerous successes, but challenges remain.

Designed to facilitate access to public financial and utilization data from hospitals in California.Uses downloadable Excel pivot tables. Data was previously in another format and titled: Hospital data query system. Data available for each calendar year from 1995 - .

Introduction -- Hospital Discharges -- Hospital Procedures -- Hospital Discharges Involving Injury and Poisoning -- Definitions -- Technical Notes.

Ch. 1. Introduction and overview -- Ch. 2. Data and methods -- Ch. 3. The Sex differential in mortality -- Ch. 4. Race/ethnicity, nativity, and adult mortality -- Ch. 5. Family composition and mortality -- Ch. 6. Religious attendance, social participation, and adult mortality -- Ch. 7. The Effects of basic socioeconomic factors on mortality -- Ch. 8. The Effect of occupational status on mortality -- Ch. 9. Health insurance coverage and mortality -- Ch. 10. Perceived health status and mortality -- Ch. 11. Functional limitations and mortality -- Ch. 12. Mental and addictive disorders and mortality -- Ch. 13. Cigarette smoking and mortality -- Ch. 14. Alcohol consumption and mortality -- Ch. 15. Exercise and mortality -- Ch. 16. The Influence of other health behaviors on mortality -- Ch. 17. Conclusion.

Overall, the idea of getting older is something that 3 in 10 Americans 40 years or older would rather not think about at all. Another 32 percent are somewhat comfortable thinking about getting older and 35 percent report being very comfortable. Being older, more educated, and in better health are associated with greater levels of comfort thinking about aging. Sixty-two percent of those 40-54 years old are somewhat or very comfortable thinking about getting older; the percentage increases to 75 percent for those 65 or older. Nearly half of those 65 and older, 47 percent, report being very comfortable thinking about getting older.

Provides access to genomic and proteomic data formats, analysis techniques, and specialized visualizations for genomic and proteomic sequence and microarray analysis

Includes functions and interactive tools for analyzing historical data, modeling data, simulating systems, developing statistical algorithms, and learning and teaching statistics.

"Features more than 80 charts and tables with detailed information about the program and the seniors and younger people with disabilities who rely on Medicare for health insurance coverage."

"The World Health Organization launched Project Atlas in 2000. The objective of this project is to collect, compile and disseminate relevant information on mental health resources in countries. The first set of publications from the project appeared in October 2001; these were updated in 2005. These publications have already established themselves as the most authoritative source of such information globally. Responding to the continued need for accurate information, WHO has fully revised and updated the Atlas" -- Page 5.

Offers research reports covering European, UK-specific, and US consumer markets. The reports analyse market drivers, sizes and trends, market segmentation, along with consumer attitudes and purchasing habits. The reports are supplemented by brief digests of relevant recent events, UK and US demographic and economic statistics and useful lists.

Part I. Specific Dietary Components -- A. Major dietary constituents -- B. Minerals -- C. Vitamins -- D. Other compounds with health relevance -- Part II. Nutritional Roles in Integrated Biological Systems -- A. Nutrient-gene mechanisms -- B. Digestive, endocrine, immune, and neural mechanisms -- Part III. Nutritional Needs and Assessment During the Life Cycle and Physiologic Changes -- Part IV. Prevention and Management of Disease -- A. Obesity and diabetes -- B. Cardiovascular diseases -- C. Pediatric and adolescent disorders -- D. Disorders of the alimentary tract -- E. Nutritional management during cancer -- F. Skeletal and joint disorders -- G. Nutrition in surgery and trauma -- H. Behavioral, psychiatric, and neurologic disorders -- I. Other systemic disorders -- J. Food additives, hazards, and nutrient-drug interactions -- Part V. Nutrition of Populations -- A. Nutrition in a changing world.

"The original targets for these Goals were a two-thirds reduction in the mortality of children under 5 and a three-quarters reduction in the maternal mortality ratio between 1990 and 2015. There is worldwide consensus that, in order to reach these targets, good-quality essential services must be integrated into strong health systems. The addition in 2007 of a new target in Goal 5--universal access to reproductive health by 2015--reinforces this consensus: all people should have access to essential maternal, newborn, child and reproductive health services provided in a continuum of care. In order to reduce maternal mortality, Emergency Obstetric Care (EmOC) must be available and accessible to all women. While all aspects of reproductive health care including family planning and delivery with the help of a skilled health professional also plays an important role in reducing maternal and neonatal mortality, this handbook focuses on the critical role of EmOC in saving the lives of women with obstetric complications during pregnancy and childbirth and saving the lives of newborns intrapartum. The handbook describes indicators that can be used to assess, monitor and evaluate the availability, use and quality of EmOC." - p. viThis handbook describes indicators that can be used to assess, monitor and evaluate the availability, use and quality of Emergency Obstetric Care. These emergency obstetric care indicators can be used to measure progress in a programmatic continuum: from the availability of and access to emergency obstetric care to the use and quality of those services.

Provides access to surveys and publications about working women, child health, and labor statistics from 1968 to the present.

The site includes data and information for each state, the District of Columbia, Puerto Rico and the United States on prenatal care, low birthweight, infant mortality, poverty, health insurance coverage, and other topics related to maternal and child health.

PEPFAR, first authorized in 2003, has supported significant advances in HIV/AIDS prevention, treatment, and care in over 30 countries, including directly supporting treatment for about 5.1 million people; however, millions more people still need treatment. PEPFAR has allocated more than half of its funding to care and treatment and has spent over $1.2 billion to purchase ARV drugs. In addition to supplying ARV drugs directly in some countries, PEPFAR also helps partner countries manage their drug supply chains. GAO was asked to review PEPFAR supported ARV drug supply chains. GAO examined (1) actions PEPFAR has taken regarding ARV drug supply chains and (2) partner-country ARV drug supply chain operations. GAO reviewed PEPFAR and the U.S. Agency for International Development (USAID) guidance and supply chain studies; analyzed 16 supply chain evaluations conducted in seven countries and published in 2011 and 2012; interviewed officials from OGAC, USAID, and other agencies; and conducted fieldwork in three countries selected on the basis of program size and other factors.

The WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation (JMP) reports every two years on progress towards the drinking-water and sanitation target under Millennium Development Goal 7. This target calls for halving the proportion of the population without sustainable access to safe drinking water and basic sanitation between 1990 and 2015. Estimates presented in its 2012 update report describe the situation at the end 2010 and supersede those of the JMP update published in March 2010. The report brings welcome news: measured by the proxy-indicator consistently used by the JMP since 2000, the MDG drinking-water target was met in 2010, five years ahead of schedule. However, the job is far from done. An estimated 780 million still lacked safe drinking water in 2010, and the world is unlikely to meet the MDG sanitation target. A reduction in urban-rural disparities and inequities associated with poverty; drinking-water coverage in countries in sub-Saharan Africa and Oceania; putting sanitation 'on track'; and universal coverage beyond 2015 all remain high on the development and public health agenda.--Publisher description.

"Basic-statistics graphical user interface (GUI) for R, a free interactive programming language and environment"--Website.

For statistical computing.

Contains more than 170 databases including these health and socioeconomic statistics databases: AIDS Diagnoses in U.S. States, Cancer Incidence and Rates in U.S. States, Drug-Related Deaths, Health Behavioral Risk Factors and Health Conditions, Medicare and Medicare Advantage Beneficiaries and Enrollees, Medicare Beneficiaries by Age, Gender, Race and Federal Poverty Level, and Transfer of Payments.

Contains over 180 databases covering all 50 states and includes data at the national, state, county, and city levels. Available sections include Health & Health Care, Population & Demographics and Social Insurance & Human Services.

Search engine specializing in finding information about the R statistical analysis language.

An interagency working group of scientific and technical information organizations from major U.S. government science agencies have collaborated to create science.gov, the "FirstGov for Science" web site. It provides a gateway to reliable information about science and technology from across federal government organizations. Major types of information included are selected authoritative science Web sites and databases of technical reports, journal citations, conference proceedings, and fact sheets.

A leading significance analysis tool for microarray gene expression measurements.

This report sets out to illuminate the different ways people seek health information as well as how people use online social tools to share knowledge with loved ones, fellow patients, and caregivers.

1. What We Know About Factors Affecting Medical Student & Resident Career Decisions -- 2. Study Aims, Questions, Methods, Limitations -- 3. Outcomes of Current Physician Training -- 4. Debt -- 5. Title VII Effect, Personal Interests, and Experiences in Medical School -- 6. Return on Investment -- 7. Conclusions and Recommendations -- Appendices.

Program that allows the user to do statistical analysis.

"All known local tobacco control ordinances in the US that have one or more of the following provisions--clean indoor air, youth access, or restrictions on tobacco advertising and promotion."

A premier source for cancer statistics in the United States. SEER collects information on incidence, survival, and prevalence from specific geographic areas representing 26 percent of the US population and compiles reports on all of these plus cancer mortality for the entire US.

Program that allows the user to calculate statistics, generate data reports and produce graphics.

Consists of the raw, single-pass, reads of DNA sequence generated from large-scale sequencing projects.

no. 1. Alabama -- no. 2. Alaska -- no. 3. Arizona -- no. 4. Arkansas -- no. 5. California -- no. 6. Colorado -- no. 7. Connecticut -- no. 8. Delaware -- no. 9. District of Columbia -- no. 10. Florida -- no. 11. Georgia -- no. 12. Hawaii -- no. 13. Idaho -- no. 14. Illinois -- no. 15. Indiana -- no. 16. Iowa -- no. 17. Kansas -- no. 18. Kentucky -- no. 19. Louisiana -- no. 20. Maine -- no. 21. Maryland -- no. 22. Massachusetts -- no. 23. Michigan -- no. 24. Minnesota -- no. 25. Mississippi -- no. 26. Missouri -- no. 27. Montana -- no. 28. Nebraska -- no. 29. Nevada -- no. 30. New Hampshire -- no. 31. New Jersey -- no. 32. New Mexico -- no. 33. New York -- no. 34. North Carolina -- no. 35. North Dakota -- no. 36. Ohio -- no. 37. Oklahoma -- no. 38. Oregon -- no. 39. Pennsylvania -- no. 40. Rhode Island -- no. 41. South Carolina -- no. 42. South Dakota -- no. 43. Tennessee -- no. 44. Texas -- no. 46. Vermont -- no. 47. Virginia -- no. 48. Washington -- no. 49. West Virginia -- no. 50. Wisconsin-- no. 51. Wyoming.

Collates the most recent country-specific data on the spread and impact of the HIV virus, together with information on risky behaviors and health sector response information (e.g. data on people receiving treatment and coverage of HIV counselling and testing).

Contains statistics on end stage renal disease (ESRD) such as life expenctancy following transplant, survival rates, prevalence and costs of ESRD therapy, international comparisons of ESRD, and treatment modalitites such as dialysis and hemodialysis.

A short history of vaccination / Susan L. Plotkin, Stanley A. Plotkin -- Vaccine immunology / Claire-Anne Siegrist -- The vaccine industry / R. Gordon Douglas, Jerald C. Sadoff, Vijay B. Samant -- Vaccine manufacturing / Phillip L. Gomez, James M. Robinson, Joseph A. Rogalewicz -- Immunologic adjuvants / Frederick R. Vogel, Stanley L. Hem -- Vaccine additives and manufacturing residuals in United States-licenced vaccines / Theresa M. Finn, William Egan -- General immunization practices / William L. Atkinson, Andrew L. Kroger, Larry K. Pickering -- Anthrax vaccines / Philip S. Brachman, Arthur M. Friedlander, John D. Grabenstein -- Cholera vaccines / Carol O. Tacket, David A. Sack -- Diphtheria toxoid / Charles R. Vitek, Melinda Wharton -- Haemophilus influenzae vaccines / Aruna Chandran, James P. Watt, Mathuram Santosham -- Hepatitis A vaccines / Anthony E. Fiore, Stephen M. Feinstone, Beth P. Bell -- Hepatitis B vaccines / Eric E. Mast, John W. Ward -- Human papillomavirus vaccines / John T. Schiller, Ian H. Frazer, Douglas R. Lowy -- Inactivated influenza vaccines / Carolyn B. Bridges ... [et al.] -- Influenza vaccine--live / Robert B. Belshe ... [et al.] -- Japanese encephalitis virus vaccines / Scott B. Halstead, Julie Jacobson -- Measles vaccines / Peter M. Strebel ... [et al.] -- Meningococcal vaccines / Dan M. Granoff, Lee H. Harrison, Ray Borrow -- Mumps vaccines / Stanley A. Plotkin, Steven A. Rubin -- Pertussis vaccines / Kathryn M. Edwards, Michael D. Decker -- Plague vaccines / E. Diane Williamson, Andrew J. Simpson, Richard W. Titball -- Pneumococcal conjugate vaccine and pneumococcal common protein vaccines / Steven Black ... [et al.] -- Pneumococcal polysaccharide vaccines / Lisa A. Jackson, Kathleen M. Neuzil -- Poliovirus vaccine-inactivated / Stanley A. Plotkin, Emmanuel Vidor -- Poliovirus vaccine-live / Roland W. Sutter, Olen M. Kew, Stephen L. Cochi -- Rabies vaccines / Stanley A. Plotkin, Hilary Koprowski, Charles E. Rupprecht -- Rotavirus vaccines / H. Fred Clark ... [et al.] -- Rubella vaccine / Stanley A. Plotkin, Susan E. Reef -- Smallpox and vaccinia / Donald A. Henderson, Luciana L. Borio, John D. Grabenstein -- Tetanus toxoid / Steven G.F. Wassilak ... [et al.] -- Tick-borne encephalitis virus vaccines / P. Noel Barrett, Stanley A. Plotkin, Hartmut J. Ehrlich -- Tuberculosis vaccines / Kim Connelly Smith, Ian M. Orme, Jeffrey R. Starke -- Typhoid fever vaccines / Myron M. Levine -- Varicella vaccine / Anne A. Gershon, Michiaki Takahashi, Jane F. Seward -- Yellow fever vaccine / Thomas P. Monath, Martin S. Cetron, Dirk E. Teuwen -- Zoster vaccine / Myron J. Levin -- Combination vaccines / Michael D. Decker, Kathryn M. Edwards, Hugues H. Bogaerts -- Adenovirus vaccines / Charlotte A. Gaydos, Gregory C. Gray -- Biodefense and special pathogen vaccines / Philip Pittman, Stanley A. Plotkin -- Therapeutic cancer vaccines / Neil L. Berinstein, David Spaner -- Cytomegalovirus vaccines / Stanley A. Plotkin -- Dengue vaccines / Scott B. Halstead, David W. Vaughn -- Diarrheal disease vaccines / James P. Nataro, Eileen M. Barry -- Ebola vaccines / Nancy J. Sullivan, Gary J. Nabel -- Epstein-Barr virus vaccines / Joanne E. Davis, Denis J. Moss -- Hepatitis C virus vaccines / Eva Reali, Michael Houghton, Sergio Abrignani -- Hepatitis E virus vaccines / Robert H. Purcell, Suzanne U. Emerson -- Herpes simplex virus vaccines / Lawrence R. Stanberry -- Human immunodeficiency virus vaccines / Marc P. Girard, Wayne C. Koff -- Lyme disease vaccines / Allen C. Steere -- Malaria vaccines / Filip Dubovsky, Elissa Malkin -- Noninfectious disease vaccines / George R. Siber -- Respiratory syncytial virus and parainfluenza virus vaccines / Ruth A. Karron -- Parasitic disease vaccines / Peter J. Hotez, Jeffrey M. Bethony -- Severe acute respiratory syndrome (SARS) vaccines / Bart L. Haagmans, Albert D.M.E. Osterhaus -- Staphylococcus aureus vaccines / Robert S. Daum -- Streptococcus group A vaccines / Karen L. Kotloff -- Streptococcus group B vaccines / C. Mary Healy, Carol J. Baker -- Technologies for making new vaccines / Ronald W. Ellis -- Alternative vaccine delivery methods / Bruce G. Weniger, Mark J. Papania -- The development of gene-based vectors for immunization / Gary J. Nabel --- Vaccination in the immunocompromised host / Per Ljungman -- Vaccination of human immunodeficiency virus-infected persons / William J. Moss, Neal A. Halsey -- Vaccines for international travel / Elizabeth D. Barnett, Phyllis E. Kozarsky, Robert Steffen -- Vaccines for health care workers / David J. Weber, William A. Rutala -- Immunization in the United States / Walter A. Orenstein ... [et al.] -- Immunization in Europe / David M. Salisbury, John S. Spika -- Immunization in the Asia-Pacific region / Theodore F. Tsai, Zhi Yi Xu -- Immunization in developing countries / Stephen C. Hadler ... [et al.] -- Community immunity / Paul E.M. Fine, Kim Mulholland -- Economic analyses of vaccine policies / Mark A. Miller, Alan R. Hinman -- Regulation and testing of vaccines / Norman W. Baylor, Karen Midthun -- Vaccine safety / Paul A. Offit, Robert L. Davis, Deborah Gust -- Legal issues / Geoffrey Evans, Emily Marcus Levine, Elizabeth H. Saindon -- Ethics / Arthur L. Caplan, Jason L. Schwartz.

Provides easy access to a large body of statistical data resources for science and engineering (S&E) at U.S. academic institutions, including life sciences.

1. Introduction -- 2. Methodology -- 3. Construction of the weight velocity standards -- 4. Construction of the length velocity standards -- 5. Construction of the head circumference velocity standards -- 6. Computation of centiles and z-scores for velocities based on weight, length and head circumference -- 7. Discussion -- 8. Bibliography -- Appendix B Model specifications of the WHO child growth velocity standards -- Appendix C Results from analyses related to regression to the mean.

I. Magnitude of falls : a worldwide overview -- II. Active ageing: a framework for the global strategy for the prevention of falls in older age -- III. Determinants of active ageing as they relate to falls in older age -- IV. Challenges for prevention of falls in older age -- V. Examples of effective policies and interventions

Second in a series of WHO reports on the global tobacco epidemic. Tracks the status of the tobacco epidemic and the impact of interventions implemented to stop it.

This landmark new report presents the first comprehensive worldwide analysis of tobacco use and control efforts. It provides countries with a roadmap to reverse the devastating global tobacco epidemic that could kill up to one billion people by the end of this century. The report outlines the MPOWER package, a set of six key tobacco control measures that reflect and build on the WHO Framework Convention on Tobacco Control.

Includes: death rates; health risk factors; preventive care utilization; and, health insurance coverage.

1. Introduction -- 2. Policies, strategies and targets for malaria control -- 3. Interventions to control malaria -- 4. Impact of malaria control -- 5. Elimination of malaria -- 6. Financing malaria control -- PROFILES -- 31 high-burden countries -- -- Annex 1. Methods for preparing the country profiles -- Annex 2. Reported malaria cases and deaths, 2008 -- Annex 3. A. Reported malaria cases, 1990--2008 -- Annex 3. B. Reported malaria deaths, 1990--2008 -- Annex 4. A. Recommended policies and strategies for malaria control, 2009 -- Annex 4. B. Antimalarial drug policy, 2009 -- Annex 5. Operational coverage of ITNs, IRS and antimalarial treatment, 2007--2008 -- Annex 6. A. Household surveys of mosquito nets ownership and usage, 2006--2008 -- Annex 6. B. Household surveys of antimalarial treatment, 2006--2008 -- Annex 7. Funding for malaria control, 2008

The World Malaria Report 2012 summarizes information received from 104 malaria-endemic countries and other sources, and updates the analyses presented in the 2011 report. It highlights the progress made towards the global malaria targets set for 2015 and describes current challenges for global malaria control and elimination.

A popular DNA motif finder applicable to finding candidates for regulatory factor binding sites by searching for statistically overrepresented motifs. It enumerates all motifs in the search space and is guaranteed to produce those motifs with greatest z-scores

Consists of publications (selectively listed in this record) issued by various units of the San Francisco Department of Public Health and listed alphabetically by title. The Knowledge Sharing & Collaboration tab contains separate lists of publications about community health, environmental health, occupational safety and health, etc.